$ACRV
Acrivon Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Acrivon Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ACRV down today? It is at $1.16 (-17.86%), and our scanner flagged it 30 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ACRV spikes, and full due diligence on ACRV — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ACRV 30 times in the last 30 days. Create a free account to track $ACRV, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how ACRV traded in the last session, Friday (last price and move above). Our scanner fired 15 unusual-volume and momentum alerts on ACRV on Friday, peaking at 121.1x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystClinical / FDA update, from the latest SEC filing. Read it →Across every filing on file, supply equal to 33.3% of the tradeable float is in play - 33.3% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
Active shelf on file — the company can issue new shares on demand (valid ~3 years)
About $300.0M in size · Baby-shelf capped: no more than one third of public float in any 12 months
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Blume-Jensen Peter Officer | Sold (automatic/other) | -1K | sold <0.1% | 2.23M | $2K at $1.45 | Nov 17, 26 |
Blume-Jensen Peter Officer | Sold (automatic/other) | -504 | sold 0.1% | 385K | $731 at $1.45 | Nov 17, 26 |
Devroe Eric Officer | Sold (automatic/other) | -628 | sold 0.4% | 146K | $911 at $1.45 | Nov 17, 26 |
Gamelin Erick Officer | Sold (automatic/other) | -416 | sold 0.8% | 52K | $603 at $1.45 | Nov 17, 26 |
Miller Mary Officer | Sold (automatic/other) | -193 | sold 0.2% | 81K | $280 at $1.45 | Nov 17, 26 |
Peterson Katharine Officer | Sold (automatic/other) | -107 | sold 0.6% | 18K | $155 at $1.45 | Nov 17, 26 |
Miller Mary Officer | Sold (automatic/other) | -513 | sold 0.6% | 81K | $944 at $1.84 | Oct 22, 26 |
Miller Mary Officer | Sold (automatic/other) | -294 | sold 0.4% | 82K | $585 at $1.99 | Oct 5, 26 |
Levin Michaela Officer | Acquired (grant/award) | +30K 0.07% of company | n/a | 30K | n/a | Aug 31, 26 |
Blume-Jensen Peter Officer | Sold (automatic/other) | -14K 0.03% of company | sold 0.6% | 2.23M | $31K at $2.21 | Aug 25, 26 |
Blume-Jensen Peter Officer | Sold (automatic/other) | -1K | sold <0.1% | 2.24M | $2K at $2.01 | Aug 18, 26 |
Blume-Jensen Peter Officer | Sold (automatic/other) | -484 | sold 0.1% | 386K | $973 at $2.01 | Aug 18, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how ACRV traded in the last session, Friday (last price and move above). Our scanner fired 15 unusual-volume and momentum alerts on ACRV on Friday, peaking at 121.1x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
ACRV last traded at $1.16, down 17.86% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The ACRV Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ACRV 30 times in the last 30 days.
ACRV (Acrivon Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $49M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ACRV for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ACRV discussion
Sign in to ask a question or join the discussion.